|
|
|
|
|
|
| · |
Dr. Yaffa Beck - Chief Executive Officer
Dr. Beck has more than 23 years of experience in drug development and management positions in the biotechnology industry. Prior to joining Obecure, she was CEO of BrainStorm Cell Therapeutics, COO of Collgard Biopharmaceuticals, COO of D-Pharm, head of Business development in Orgenics and Head of Scientific Development in Biotechnology General Israel.
She serves on advisory committees of the Chief Scientist Office of the Israel Ministry of Trade and Industry, dealing in infrastructural research and biotech incubator projects.
Trained as a molecular biologist, Dr. Beck holds a D.Sc. from the University of Pretoria, South Africa (1982), and a Management and Administration diploma from Bradford University , UK (1997). |
| |
|
 |
|
|
|
|
|
|
|
|
| · |
Dr. Nir Barak M.D. - Chief Scientific Officer
Dr Barak is a graduate of the Sackler School of Medicine at Tel Aviv University, specialized in internal medicine. Dr Barak also trained in clinical nutrition at the University of Chicago Hospital and a earned a Certified Nutrition Support Physician (CNSP) degree from the American Society of Parenteral and Enteral Nutrition. Dr Barak works as an attending physician in the medical service of Rabin Medical Center and is the head of the Obesity Clinic of Leumit HMO. He serves as a member in the Israeli Society of Internal Medicine, the Israeli Society of Clinical Nutrition and the Israeli Society for Obesity Research and coauthored the Israeli guidelines for Total Parenteral Nutrition, Percutaneous Feeding Gastrectomy, and Re-feeding Syndrome. |
| |
|
|
|
|
|
|
|
|
|
|
| · |
Mr. Richard Naimer - Chief Operating Officer, Director
Mr. Naimer is a founder and general partner of Bio-Light Israel Life Science Investments Ltd. A graduate of the Bar Ilan University Law School , Mr. Naimer was admitted to the Israeli Bar Association in 1992. Richard joined the Firm of Granot & Co. as a junior associate and thereafter joined the firm as a full partner, subsequently heading the firm's International and Venture Capital Department. In this context Richard specialized in venture capital investments, taxation and representation of start up companies in the fields of information technology and biotechnology. Richard also serves as the Israeli representative of Eurohypo, one of the leading European mortgage banks. |
| |
|
|
|
|
|
|
|
|
|
|
| · |
Dr. Ami Eyal M.D. - Clinical Director, Director
Dr. Eyal is a founder and general partner of Bio-Light Israel Life Science Investments Ltd. Dr. Eyal has focused his career on life sciences entrepreneurship and investments. Among the companies in which he has invested in and co-founded are Can-Fite, Spectrum Dynamics, Raphael Medical, C-Beyond Bio Medical Strategy and others. A graduate of the Tel Aviv University Medical School, Dr. Eyal specialized in general surgery and serves in the emergency unit of the Sourasky Medical Center. He also serves in the IDF Air Force reserves as a pilot and senior medical officer. |
| |
|
|
|
|
|
|
|
|
|
|
| · |
Ms. Ronit Gross - Business Development, Director
Ms. Gross is a founder and general partner of Bio-Light Israel Life Science Investments Ltd. Ms. Gross is a member of the Israeli and New York Bar Associations. After graduating from Tel Aviv University Law School , she earned her LLM in corporate law at New York University Ms. Gross practiced law in New York City for several years, first with the firm of Schulte Roth & Zebel and then with the corporate department of Thelen Reid & Priest. Since returning to Israel in 1995, she has focused on the creation of and investment in hi-tech, biotech and medical device companies. |
| |
|
|
|
|
|
|
|
|
|
|
| · |
Dr. Gal Ehrlich - Director of Intellectual Property, Director
Dr. Ehrlich is a founder and general partner of Bio-Light Israel Life Science Investments Ltd. Dr. Ehrlich is recognized as the owner of the leading and fastest growing intellectual property firm in Israel - Ehrlich & Fenster. Trained in molecular biology, Dr. Ehrlich holds a Ph.D from the Hebrew University of Jerusalem and a law degree from Tel Aviv University . Since 1994, Dr. Ehrlich has been involved in preparing patent applications in a wide range of industries, mainly in the biotechnology field but also in pharmaceuticals, medical devices. agrotech and hi-tech. |
| |
|
|
|
|
|
|
|
|
|
|
| · |
Dr. Mickey Averbuch M.D. - Regulatory Affairs
Dr. Averbuch received his medical training at the Technion School of Medicine and graduated in 1983. He specialized in internal medicine at the Tel Aviv Sourasky Medical Center and in clinical pharmacology at the University Of Rochester School Of Medicine .
Trained in regulatory affairs, he served as a Medical Officer at the FDA - CDER. He is a long-term member of the National Hospital Formulary in Israel and the Supreme Advisory Committee for Appeals in Drug Registration in Israel . Since 2001 he also serves as a member of the National Committee for Generic Drugs Registration in Israel .
He is currently a practicing physician at the Tel Aviv Sourasky Medical Center and a senior lecturer at the Tel Aviv University Faculty of Medicine |
| |
|
|
|
|
|
|
|
|
|
|
| · |
Mr. Amos Eiran - Chairman of the Board of Directors
Amos Eiran is chairman of the board of Bio-Light Israel Life Science Investments Ltd. He is also chairman of Atudot, a major Israeli pension fund, chairman of the investment committee of Clal Insurance Group, an Israeli insurance company, and chairman of Tissera, a life science company specializing in tissue transplantation. He also serves as director of Delek Oil Exploration. Mr. Eiran has been a director of Medis Technologies (NASDAQ : MDTL) since 1997 and is also a director of two subsidiaries, Medi and Medis El. Mr. Eiran served as general manager of the Prime Minister's office during Yitzhak Rabin's first term as prime minister. Prior to that, he was general manager and chairman of Mivtahim, the largest pension fund in Israel. Mr. Eiran received a B.A. from American University in Washington D.C. , an M.A. in History from Tel Aviv University and business degrees from Harvard University and Wharton School of Business. |
| |
|
|
|
|
|
|
|
|
|
|
| Advisors |
|
|
|
|
|
|
| · |
Dr. Robert F. Kushner M.D. - Advisor on metabolic diseases
A professor of medicine in Northwestern University in Chicago and Medical Director of the Wellness Institute at Northwestern Memorial Hospital , Dr. Kushner is an internationally acclaimed weight management expert. Board certified in internal medicine and nutrition, Dr. Kushner has treated thousands of overweight patients and has 21 years of experience in the weight loss field. He is the author of the American Medical Association's newly released Obesity Treatment Guide for Physicians. Moreover, he conducts workshops to train physicians on how to manage overweight patients, at the seven prestigious Centers for Obesity Research and Education (C.O.R.E.). A noted national and international speaker, Dr. Kushner has addressed the National Institutes of Health (NIH), the Federal Trade Commission (FTC) and Harvard Medical School and appeared on Good Morning America and CNN. In 2001-2004, Dr. Kushner was listed in Best Doctors in America . |
| |
|
|
|
|
|
|
|
|
|
|
| · |
Dr. Joseph Albeck, M.D. - Advisor on psychiatric disease
A practicing clinical psychiatrist, Dr. Albeck is a clinical instructor in Psychiatry at McLean Hospital of the Harvard Medical School . In the past decade he has served as chairman of Intergenerational Aspects of Trauma for the International Society for Traumatic Stress Studies,
Moreover, he serves as President of To Reflect and Trust, Inc., a non-profit organization that works with groups in conflict areas, including Israel/Palestine, Northern Ireland , and South Africa and was a founder of the New England Holocaust Memorial. |
| |
|
|
|
|
|
|
|
|
|
|
| · |
Dr. Allan M. Green M.D., Ph.D., J.D. - Advisor on regulatory affairs
Dr. Allan Green is an attorney and physician in Cambridge , Massachusetts His law firm focuses on FDA regulatory matters and biomedical business counseling ( www.fdaregs.com ). Trained in medicine, basic research and law, he has both advisory and operating management experience. Formerly the medical director of New England Nuclear/Dupont Medical Products and Of Counsel to Mintz, Levin, P.C., he has been a principal in a number of start-up biomedical firms including Theseus Imaging, Neurochem, Atherochem and Immune Control. He has served on various government committees as a technical consultant, held several medical school appointments and is the author of many papers on drug development and regulation. He is a director of the non-profit Institute for the Study of Aging.
Dr. Green received his B.S. in economics in 1966 and his Ph.D. in biochemistry and metabolism in 1971, both from the Massachusetts Institute of Technology. He received his M.D. from Case Western Reserve University School of Medicine in 1972 and holds Board certification in both Internal Medicine and in Nuclear Medicine. He received his J.D. from Boston College Law School in 1991. |
| |
|
|
|
|
|
|
|
|
|
|
